The study concluded that JAK2-V617F patients had more circulating PMPs and higher procoagulant activities than CALR-mutated or triple-negative ET patients, indicating the key role of circulating particles in higher thrombotic risk induction [148]. This evidence concerns the gene JAK2 and essential thrombocythemia.